Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Frontiers in Medicine|April 16, 2026
Correction: The DANIsh VASculitis cohort study: protocol for a national multicenter prospective study including incident and prevalent patients with giant cell arteritis and polymyalgia rheumaticaBerit D Nielsen, Salome Kristensen, Agnete Donskov, et al.
BMC Musculoskeletal Disorders|March 14, 2012
Feasibility of a standardized ultrasound examination in patients with rheumatoid arthritis: a quality improvement among rheumatologists cohortKaren Ellegaard, Søren Torp-Pedersen, Robin Christensen, et al.
Therapeutic Advances in Musculoskeletal Disease|December 29, 2025
Safety outcomes in 2132 Danish patients with inflammatory arthritis treated with biosimilar infliximab (GP1111) in routine careHafsah Nabi, Kasper Yde Jensen, Rasmus Westermann, et al.
Medicine|June 29, 2017
Polymyalgia rheumatica and giant cell arteritis-three challenges-consequences of the vasculitis process, osteoporosis, and malignancy: A prospective cohort study protocolAmir Emamifar, Søren Hess, Oke Gerke, et al.
Annals of the Rheumatic Diseases|April 30, 2021
Comparative effectiveness of two adalimumab biosimilars in 1318 real-world patients with inflammatory rheumatic disease mandated to switch from originator adalimumab: nationwide observational study emulating a randomised clinical trialHafsah Nabi, Stylianos Georgiadis, Anne Gitte Loft, et al.
Rheumatology (Oxford, England)|December 3, 2015
Impact of tobacco smoking on response to tumour necrosis factor-alpha inhibitor treatment in patients with ankylosing spondylitis: results from the Danish nationwide DANBIO registryBente Glintborg, Pil Højgaard, Merete Lund Hetland, et al.
RMD Open|November 23, 2022
Infliximab biosimilar-to-biosimilar switching in patients with inflammatory rheumatic disease: clinical outcomes in real-world patients from the DANBIO registryHafsah Nabi, Oliver Hendricks, Dorte Vendelbo Jensen, et al.
Annals of the Rheumatic Diseases|May 6, 2017
A nationwide non-medical switch from originator infliximab to biosimilar CT-P13 in 802 patients with inflammatory arthritis: 1-year clinical outcomes from the DANBIO registryBente Glintborg, Inge Juul Sørensen, Anne Gitte Loft, et al.
Annals of the Rheumatic Diseases|November 7, 2018
To switch or not to switch: results of a nationwide guideline of mandatory switching from originator to biosimilar etanercept. One-year treatment outcomes in 2061 patients with inflammatory arthritis from the DANBIO registryBente Glintborg, Anne Gitte Loft, Emina Omerovic, et al.
The Journal of Rheumatology|July 3, 2018
Assessing Vasculitis in Giant Cell Arteritis by Ultrasound: Results of OMERACT Patient-based Reliability ExercisesValentin S Schäfer, Stavros Chrysidis, Christian Dejaco, et al.
Pageof 3